The Impact of A3AR Antagonism on the Differential Expression of Chemoresistance-Related Genes in Glioblastoma Stem-like Cells

• Published in: Pharmaceuticals (Basel, Switzerland) Vol. 17; no. 5; p. 579
• Main Authors: Peñate, Liuba, Carrillo-Beltrán, Diego, Spichiger, Carlos, Cuevas-Zhbankova, Alexei, Torres-Arévalo, Ángelo, Silva, Pamela, Richter, Hans G, Ayuso-Sacido, Ángel, San Martín, Rody, Quezada-Monrás, Claudia
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01-05-2024
• Subjects: Adenosine; Brain cancer; Cancer; Care and treatment; chemoresistance; Chemotherapy; Comparative analysis; Diagnosis; Dosage and administration; Drug resistance; Genetic aspects; Genotype & phenotype; glioblastoma; Glioblastoma multiforme; glioblastoma stem-like cells; Glioma; Health aspects; Hypoxia; Influence; Medical prognosis; Nervous system; Patient outcomes; Physiological aspects; Prognosis; Risk factors; Survival analysis; Tumors; Chile; adenosine; glioblastoma stem-like cells; chemoresistance; glioblastoma
• ISSN: 1424-8247; 1424-8247
• DOI: 10.3390/ph17050579

Glioblastoma (GB) is the most aggressive and common primary malignant tumor of the brain and central nervous system. Without treatment, the average patient survival time is about six months, which can be extended to fifteen months with multimodal therapies. The chemoresistance observed in GB is, in part, attributed to the presence of a subpopulation of glioblastoma-like stem cells (GSCs) that are characterized by heightened tumorigenic capacity and chemoresistance. GSCs are situated in hypoxic tumor niches, where they sustain and promote the stem-like phenotype and have also been correlated with high chemoresistance. GSCs have the particularity of generating high levels of extracellular adenosine (ADO), which causes the activation of the A
adenosine receptor (A3AR) with a consequent increase in the expression and activity of genes related to chemoresistance. Therefore, targeting its components is a promising alternative for treating GB. This analysis determined genes that were up- and downregulated due to A3AR blockades under both normoxic and hypoxic conditions. In addition, possible candidates associated with chemoresistance that were positively regulated by hypoxia and negatively regulated by A3AR blockades in the same condition were analyzed. We detected three potential candidate genes that were regulated by the A3AR antagonist MRS1220 under hypoxic conditions:
,
, and
. Finally, the selected markers were correlated with hypoxia-inducible genes and with the expression of adenosine-producing ectonucleotidases. In conclusion, we detected that hypoxic conditions generate extensive differential gene expression in GSCs, increasing the expression of genes associated with chemoresistance. Furthermore, we observed that MRS1220 could regulate the expression of
,
, and
, which are involved in chemoresistance and correlate with a poor prognosis, hypoxia, and purinergic signaling.